Clinical Case and Follow-Up of Babesia banethi Infection in a Red Fox. [PDF]
Carbonara M +7 more
europepmc +1 more source
Promising Drug Repurposing Candidates Targeting Free-Living Amoebae: A Systematic and Critical Review of Laboratory-Based Evidence. [PDF]
Chaúque BJM +14 more
europepmc +1 more source
Bibenzyl Derivatives from <i>Radula voluta</i> (An Ecuadorian Liverwort): Bioprospecting for Antiprotozoal Properties. [PDF]
Andrade JM +10 more
europepmc +1 more source
Delayed Pathogenicity in <i>Toxoplasma gondii</i> as an Evolutionary Framework for Late-Life Disease and Mortality. [PDF]
Israel A, Israel S.
europepmc +1 more source
Antiprotozoal Activity of Artemisia vulgaris and Berberis vulgaris Against Leishmania major and Trichomonas vaginalis. [PDF]
Aksoy T +3 more
europepmc +1 more source
Molecular mechanisms underlying drug resistance in protozoan parasites: emerging mechanisms and therapeutic perspectives. [PDF]
Uduwela K, Ranasinghe K.
europepmc +1 more source
A Two-Phase Approach to the Use of Tafenoquine Was Associated with Cure of Babesiosis in Two Immunocompromised Patients with Relapsing Babesiosis. [PDF]
Osakwe N, Wormser GP.
europepmc +1 more source
Antiprotozoal Effects of <i>Pediococcus acidilactici</i>-Derived Postbiotic on <i>Blastocystis</i> Subtypes ST1/ST3. [PDF]
Aydemir S +6 more
europepmc +1 more source
Mangiferin inhibits multiple stages of the <i>Toxoplasma gondii</i> lytic cycle <i>in vitro</i> and protects against acute RH strain infection <i>in vivo</i>. [PDF]
Gao S +9 more
europepmc +1 more source

